Last10K.com

Ge Healthcare Technologies Inc. (GEHC) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2022

SEC Filings

GEHC Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

GEHC Annual Reports

    10-K Annual Report February 2024
  • 10-K Annual Report February 2023

GEHC Quarterly Reports

GEHC Corporate News

GEHC Registration of Securities

Ge Healthcare Holding Llc

HISTORY TOOLS
CIK: 1932393 Ticker: GEHC
ge-hlthcr_standardxrgbxgeh.jpg
Exhibit 99
GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
•4Q Revenues up 8% year-over-year, Organic revenues* up 13%

•4Q Net income of $554 million versus $564 million for the prior year, Adjusted EBIT* of $844 million versus $827 million

•4Q EPS were $1.21 versus $1.24 in the prior year, Adjusted EPS* were $1.31 versus $1.36

•Reaffirmed 2023 guidance disclosed earlier this month; introduced 2023 Adjusted EPS* guidance

Chicago, IL – January 30, 2023 –
GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the fourth quarter and full year ended December 31, 2022.
GE HealthCare President and CEO Peter Arduini said, “GE HealthCare delivered strong revenue growth in the fourth quarter and full year 2022 driven by robust end market demand, improved pricing, and easing supply chain pressures. Revenue growth reflects our progress to offset delivery challenges and improve product fulfillment."

Arduini continued, "Looking ahead, we're confident that our accelerated investment in innovation, as well as standardization across platforms, will drive revenue and margin growth. We're seeing customers continue to invest along with macroeconomic tailwinds, such as increasing healthcare digitization, expanding access to care, and an aging population globally. We are well positioned to deliver on our 2023 commitments.”

Fourth quarter 2022 total financial performance
•Revenues of $4.9 billion increased 8% and 13% on an Organic basis* year-over-year, driven by growth in Imaging, Patient Care Solutions (PCS), and Ultrasound. Acquisitions favorably impacted total revenue growth by 1% and foreign exchange negatively impacted growth by 6%. Total company book-to-bill, defined as Total orders divided by Total revenues within a given financial period, was 1.07 times for the quarter, led by strong order growth in Imaging and Ultrasound.
•Net income was $554 million versus $564 million for the prior year, and Adjusted EBIT* was $844 million versus $827 million.
•Net income margin was 11.2% versus 12.3% for the prior year, and Adjusted EBIT margin* was 17.1% versus 18.0%. Both measures were impacted by inflation, mix, planned R&D investment, and foreign exchange headwinds, partially offset by price and volume gains. Standalone Adjusted EBIT margin* for the fourth quarter of 2022 is estimated at 16.1%, which includes the impact of standalone costs.
•Earnings per share (EPS) from continuing operations were $1.21, compared to $1.24 in the prior year. Adjusted EPS* were $1.31, compared to $1.36 in the prior year. Standalone Adjusted EPS* for the fourth quarter of 2022 were estimated at $1.06, which includes the impact of standalone costs, interest, and tax.
•Cash flow from operating activities was $1.1 billion, up $1.1 billion year-over-year, and Free cash flow* was $987 million, up $436 million year-over-year with improvement in supply chain and collections.



* Non-GAAP financial measure.

The following information was filed by Ge Healthcare Holding Llc (GEHC) on Monday, January 30, 2023 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Ge Healthcare Holding Llc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ge Healthcare Holding Llc.

Continue

Assess how Ge Healthcare Holding Llc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ge Healthcare Holding Llc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Earnings
Product
Cash Flow
Income
Geography
Expense
Shares
Other
Inside Ge Healthcare Holding Llc's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Audit Information
Cover
Ticker: GEHC
CIK: 1932393
Form Type: 10-K Annual Report
Accession Number: 0001932393-23-000025
Submitted to the SEC: Wed Feb 15 2023 8:46:32 AM EST
Accepted by the SEC: Wed Feb 15 2023
Period: Saturday, December 31, 2022
Industry: X Ray Apparatus And Tubes And Related Irradiation Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/gehc/0001932393-23-000025.htm